Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03370016 · ClinicalTrials.gov registry record · NA
The Impact of Low Pressure Pneumo in RARP
A NA study of Prostate Cancer, sponsored by Metro Health, Michigan.
- Completed
- Registry status
- NA
- Development phase
- 222
- Enrollment target
- 1
- Study location
NCT03370016: Completed NA study of Prostate Cancer, sponsored by Metro Health, Michigan.
NCT03370016 is a NA study of Prostate Cancer that has completed, run by Metro Health, Michigan. The registered enrollment target is 222 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03370016, a NA study of Prostate Cancer, has completed, sponsored by Metro Health, Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 222 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate clinical significance of low pressure pneumoperitoneum during robotically assisted radical prostatectomy (RARP).
Primary Outcome
Reduction in the occurrence of Post-Operative Ileus after RARP
Conditions Studied
Interventions
- PROCEDURE Amount of Pneumoperitoneum Pressure applied during RARP
Study Locations (1)
Michigan
- Metro Health - Wyoming
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 222 participants |
| Start Date | 2017-10-17 |
| Est. Completion | 2020-06-30 |
| Phase | NA |
What the finished NCT03370016 record still lists
NCT03370016 is an interventional study that assigns participants to a tested intervention. The registered 222 participants enrollment target is mid-sized for trials with a published cap, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (63% lower).
The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which Amount of Pneumoperitoneum Pressure applied during RARP is the first listed.
NCT03370016 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT03370016 about?
NCT03370016 is a clinical study titled "The Impact of Low Pressure Pneumo in RARP". The purpose of this study is to evaluate clinical significance of low pressure pneumoperitoneum during robotically assisted radical prostatectomy (RARP).
What is the current status of trial NCT03370016?
This trial is currently completed. It is a NA study. The enrollment target is 222 participants. The study started on 2017-10-17. Estimated completion is 2020-06-30.
What conditions does trial NCT03370016 study?
This clinical trial studies the following conditions: Prostate Cancer.
What interventions are being tested in trial NCT03370016?
The interventions under investigation include: Amount of Pneumoperitoneum Pressure applied during RARP (PROCEDURE).
Who is sponsoring clinical trial NCT03370016?
This trial is sponsored by Metro Health, Michigan, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03370016 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03370016's enrollment target sits among peer trials
222 206th of 735 higher than 529 of 735 other Prostate Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Prostate Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
RECRUITING · NA
-
Diffusion Basis Spectrum Imaging of the Prostate
RECRUITING · NA
-
Micro-UltraSound In Cancer - Active Surveillance
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
SBRT Boost for Unfavorable Prostate Cancer'
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04939610 · 222 participants · Phase 1
A Study of 177Lu-FAP-2286 in Advanced Solid Tumors
- NCT05568264 · 222 participants · NA
Effects of a Physical Therapy Intervention on Motor Delay in Infants Admitted to a Neonatal Intensive Care Unit
- NCT05605574 · 222 participants · NA
Longitudinal Early Advance Care Planning Discussions and Documentation (LEADD) Program: An Exploratory Study in Adolescents and Young Adults (AYAs) Receiving Hematopoietic Stem Cell Transplant
- NCT06124157 · 222 participants · Phase 3
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI